Skip to content

Comparison of the Efficacy of Endoscopy and Percutaneous Drainage in Cerebral Hemorrhage: A Multicenter Randomized Controlled Trial

Comparison of the Efficacy of Endoscopy and Percutaneous Drainage in Cerebral Hemorrhage: A Multicenter Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098017
Enrollment
Unknown
Registered
2025-02-28
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage

Interventions

Treat Group:Endoscopic therapy + the best conservative treatment
Control Group:Puncture drainage + best conservative treatment

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-80 years old; (2) For CT-confirmed basal ganglia hemorrhage, the volume of hematoma was 30-80ml based on ABC/2 method; (3) Admission GCS score 8-14; (4) Surgical intervention within 48 hours of onset; (5) Pre-onset modified Rankin Scale score (mRS) <=1 score; (6) Sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Cerebral hemorrhage caused by trauma, tumor stroke, cerebral infarction, aneurysm rupture, vascular malformation rupture, moyamoya disease, etc.; (2) Manifestations of cerebral hernia: unilateral pupil enlargement; (3) The volume of ventricle hemorrhage exceeds 50% on either side; (4) Abnormal coagulation function; Platelet count 1.4. (5) previous oral anticoagulant drugs; (6) Long-term oral anticoagulants are needed in the later stage; (7) Multiple cerebral hemorrhage; (8) Patients with serious diseases, such as malignant tumors, chronic liver disease, chronic kidney disease, chronic heart disease, etc.; (9) Expected survival time <6 months; (10) Abandonment of treatment during hospitalization; (11) Pregnant women.

Design outcomes

Primary

MeasureTime frame
The utility-weighted Modified Rankin Scale (UW-mRS) score;

Secondary

MeasureTime frame
Hematoma clearance rate;3 months mRS Score;Stroke-associated pneumonia;

Countries

China

Contacts

Public ContactYou Chao

West China Hospital, Sichuan University

youchao@vip.126.com+86 189 8060 1505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026